ALK-Abelló

Company Description

ALK-Abello A/S is a Denmark-based pharmaceutical company specializing in allergy treatment, prevention, and diagnosis. Its main businesses include allergy vaccines (tablet, sublingual, subcutaneous), emergency treatments for anaphylaxis, and allergy diagnostics products like skin-prick tests. The company operates worldwide through subsidiaries, production units, and distributors in countries such as Austria, Canada, France, Italy, the Netherlands, Poland, Spain, Switzerland, the United States, and China. In the last fiscal year, the company had 2753 employees, a market cap of $6128 millions, profits of $493 millions, and revenue of $769 millions.

Analysis

ANALYSIS: With an Obermatt 360° View of 76 (better than 76% compared with alternatives) for 2025, overall professional sentiment and financial characteristics for the stock ALK-Abelló are very positive. The 360° View is based on consolidating four consolidated indicators, with all but one indicator above average for ALK-Abelló. The consolidated Growth Rank has a good rank of 93, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth, as well as stock returns. This means that growth is higher than for 93% of competitors in the same industry. The consolidated Safety Rank at 58 means that the company has a financing structure that is safer than 58% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. Finally, the consolidated Sentiment Rank has a good rank of 90, which means that professional investors are more optimistic about the stock than for 90% of alternative investment opportunities. But the consolidated Value Rank is less desirable at 1, meaning that the share price of ALK-Abelló is on the higher side compared with indicators such as revenues, profits, and invested capital. This means the stock price is higher than for 99% of alternative stocks in the same industry. ...read more

Country

Denmark

Industry Pharmaceuticals

Size Small

Website alk.net

Index

Add to Watchlist

See Similar Stocks

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.